$TOMZ

TOMI Reports 124% Increase in Preliminary Second Quarter Revenue; Preliminary Six Months Revenue Combined with Open Orders Surpass Full Year 2025 Revenue

TOMI Environmental Solutions (NASDAQ: TOMZ) reported preliminary Q2 2026 revenue of about $2.3 million, up 124% year over year, and said open orders of $6.2 million already exceed full-year 2025 revenue. It cited higher revenue across equipment, accessories, support services, applicators, and BIT Solution, with gross margin at 70%.

Original reporting
Published Jul 9, 2026, 1:30 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 9, 2026, 2:27 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
TOMI Reports 124% Increase in Preliminary Second Quarter Revenue; Preliminary Six Months Revenue Combined with Open Orders Surpass Full Year 2025 Revenue — source image
Decision brief

The 30-second read

$TOMZBullishMed
01

Why it matters

The company’s preliminary 2Q26 revenue surge and open-orders total that already exceeds full-year 2025 revenue can shift near-term expectations for revenue run-rate and gross margin trajectory, especially given segment-level growth and reported gross margin expansion.

02

Market read

Quantified preliminary revenue growth, gross margin expansion, and open-orders momentum that already surpass full-year 2025 revenue are actionable for positioning ahead of final results.

03

What to watch

The release does not provide guidance for full-year 2026 or cash flow details; traders may need confirmation on order conversion rates and any customer concentration risk behind the “major healthcare facility” and NV+ deployment.

Relevance 8/10Novelty 8/10Timing: pre-market today, ahead of the company’s next formal quarterly results

Background

TOMI Environmental Solutions markets SteraMist iHP disinfection systems and recurring consumables (BIT Solution, accessories) with service and enclosure solutions.

Company-level read

Ticker impact

$TOMZBullishMedium confidence
Context

TOMI (TOMZ) reports preliminary 2Q26 revenue of about $2.3M, up 124% YoY, plus $6.2M open orders surpassing full-year 2025 revenue.

Expected impact

Likely positive bias for TOMZ shares into the next earnings update, with upside contingent on converting open orders into recognized revenue.

Evidence & confidence

The release provides multiple quantified preliminary datapoints (revenue, segment growth, gross margin expansion, and open orders) and a mid-year sales figure for BIT Solution, which can re-rate expectations even without final audited results.

Market effects

Supports the narrative of demand for disinfection and decontamination technologies tied to healthcare and public health preparedness.

Primarily US healthcare and public health demand signals, with distributor expansion into South Africa and Argentina.

Highlights continued global adoption of iHP/SteraMist systems and consumables across life sciences and emergency response.

Counterpoint

Preliminary figures may be subject to change, and open orders may not fully translate into revenue within the expected timeframe.

Key entities

  • TOMI Environmental Solutions, Inc.

    NASDAQ-listed disinfection and decontamination solutions provider reporting preliminary 2Q26 results and open orders.

  • SteraMist iHP systems

    Installed-base platform driving recurring high-margin consumables and services.

  • BIT Solution

    Recurring consumables line whose mid-year sales including open orders exceed $700,000.

  • NV+ system

    New customized enclosure system sold to a major healthcare facility, delivery scheduled for Q3.

Related articles

$TOMZMed

TOMI Environmental Solutions, Inc. (TOMZ): Results of Operations and Financial Condition

TOMI Environmental Solutions, Inc. (TOMZ) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 tomz_ex991.htm PRESS RELEASE tomz_ex991.htm EXHIBIT 99.1 FOR IMMEDIATE RELEASE TOMI Environmental Solutions, Inc. Reports Second Quarter 2026 Financial Results Company Delivers 118% Q2 Revenue Growth, Reaffirms Full-Year 2026 Guidance of $12 Million (113% YoY Growth) FR

$TOMZMed

TOMI Environmental Solutions, Inc. (TOMZ): Results of Operations and Financial Condition

TOMI Environmental Solutions, Inc. (TOMZ) filed an SEC Form 8-K — Results of Operations and Financial Condition. tomz_8k.htm 0000314227 false 0000314227 2026-07-29 2026-07-29 iso4217:USD xbrli:shares iso4217:USD xbrli:shares UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 D

$TOMZMed

TOMI Environmental Solutions, Inc.: TOMI Environmental Solutions Reaffirms $12 Million Revenue Guidance for Fiscal 2026 and Confirms $35 Million Sales Pipeline with $8.6 Million in Advanced Stages

TOMI Environmental Solutions (NASDAQ: TOMZ) reaffirmed fiscal 2026 revenue guidance of at least $12 million and said it has a $35 million sales pipeline, including about $8.6 million in advanced stages. The company reported booked orders of $6.2 million and Q2 growth across key metrics. TOMI also said its Carbonium merger remains on track for H2 2026.

$TOMZMedAI 9/10

Global Norovirus Outbreaks, Ebola Emergency and Rising Disease Threats Highlight Growing Need for TOMI Environmental Solutions' SteraMist Technology

TOMI Environmental Solutions (NASDAQ: TOMZ) said NASA selected its SteraMist ionized hydrogen peroxide (iHP) technology for a Mars Sample Return biosecurity operation. The company also cited rising infectious-disease alerts, including norovirus outbreaks and Ebola-related concerns, as driving demand for scalable disinfection in hospitals, hotels, cruise lines, schools and government sites.

$TOMZMedAI 8/10

TOMI Expands European Footprint with New Regulatory Approvals for Binary Ionization Technology

TOMI Environmental Solutions (NASDAQ: TOMZ) said it received official EU regulatory approvals for its Binary Ionization Technology (BIT) in Austria and Italy under the Biocidal Products Regulation. With these additions, BIT is authorized in Austria, Italy, the Netherlands, Belgium, Denmark, Germany, Hungary, Great Britain, and Northern Ireland; it has been a PT2 disinfectant in the Netherlands since March 2026.

$TOMZMedAI 8/10

TOMI Environmental Solutions, Inc. Scales Food Safety Presence with SteraMist Hybrid Installation at Expanded Food Facility

TOMI Environmental Solutions (NASDAQ: TOMZ) said it signed a purchase order for a custom SteraMist Hybrid system for a food producer. The customer previously used TOMI’s SteraMist SteraPak since 2024 and is now expanding to a permanent facility installation to support continuous regulatory compliance and reduce contamination risk, according to TOMI.